Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 292

The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.

Envelope Structures of Gram-Positive Bacteria

Open access
Rajagopal, Mithila, Walker, Suzanne·2015·Current Topics in Microbiology and Immunology

Abstract

Gram-positive organisms, including the pathogens Staphylococcus aureus, Streptococcus pneumoniae and Enterococcus faecalis, have dynamic cell envelopes that mediate interactions with the environment and serve as the first line of defense against toxic molecules. Major components of the cell envelope include peptidoglycan, which is a well-established target for antibiotics, teichoic acids, capsular polysaccharides, surface proteins, and phospholipids. These components can undergo modification to promote pathogenesis, decrease susceptibility to antibiotics and host immune defenses, and enhance survival in hostile environments. This chapter will cover the structure, biosynthesis and important functions of major cell envelope components in Gram-positive bacteria. Possible targets for new antimicrobials will be noted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/82_2015_5021

Cites

324 of 324 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Archibald AR, Baddiley J, Heptinstall S (1973) The alanine ester content and magneisum binding capacity of walls of Staphylococcus aurues H grown at different pH values. Biochim Biophys Acta 291(3):629–634 · doi:10.1016/0005-2736(73)90468-9
  2. Benson TE, Marquardt JL, Marquardt AC, Etzkorn FA, Walsh CT (1993) Overexpresson, purification, and mechanistic study of UDP-N-acetylenolpyruvylglucosamine reductase. Biochemistry 32(8):2024–2030 · doi:10.1021/bi00059a019
  3. Boneca IG, Huang ZH, Gage DA, Tomasz A (2000) Characterization of Staphylococcus aureus cell wall glycan strands, evidence for a new β-N-acetylglucosaminidase activity. J Biol Chem 275(14):9910–9918 · doi:10.1074/jbc.275.14.9910
  4. Bouhss A, Mengin-Lecreulx D, Blanot D, van Heijenoort J, Parquet C (1997) Invariant amino acids in the Mur peptide synthetases of bacterial peptidoglycan synthesis and their modification by site-directed mutagenesis in the UDP-MurNAc:l-alanine ligase from Escherichia coli. Biochemistry 36(39):11556–11563 · doi:10.1021/bi970797f
  5. Calix JJ, Brady AM, Du VY, Saad JS, Nahm MH (2014) Spectrum of pneumococcal serotype 11A variants results from incomplete loss of capsule O-acetylation. J Clin Microbiol 52(3):758–765 · doi:10.1128/jcm.02695-13
  6. Davies TA, Page MG, Shang W, Andrew T, Kania M, Bush K (2007) Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrob Agents Chemother 51(7):2621–2624 · doi:10.1128/aac.00029-07
  7. De Velasco EA, Merkus D, Anderton S, Verheul AF, Lizzio EF, Van der Zee R, Van Eden W, Hoffman T, Verhoef J, Snippe H (1995) Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysacchride conjugate vaccines. Infect Immun 63(3):961–968 · doi:10.1128/iai.63.3.961-968.1995
  8. Farha MA, Koteva K, Gale RT, Sewell EW, Wright GD, Brown ED (2014) Designing analogs of ticlopidine, a wall teichoic acid inhibitor, to avoid formation of its oxidative metabolites. Bioorg Med Chem Lett 24(3):905–910 · doi:10.1016/j.bmcl.2013.12.069
  9. Fiedel BA, Jackson RW (1978) Activation of the alternative complement pathway by a streptococcal lipoteichoi acid. Infect Immun 22(1):286–287 · doi:10.1128/iai.22.1.286-287.1978
  10. Filipe SR, Pinho MG, Tomasz A (2000) Characterization of the murMN operon involved in the synthesis of branched peptidoglycan peptides in Streptococcus pneumoniae. J Biol Chem 275(36):22768–27774 · doi:10.1074/jbc.m004675200
  11. Fuda C, Suvorov M, Vakulenko SB, Mobashery S (2004) The basis for resistance to β-lactam antibiotics by penicillin-binding protein 2A of Methicillin-resistant Staphylococcus aureus. J Biol Chem 279:40802–40806 · doi:10.1074/jbc.m403589200
  12. Hayashi H, Araki Y, Ito E (1973) Occurence of glucosamine residues with free amino groups in cell wall peptidoglycan from bacilli as a factor responsible for resistance to lysozyme. J Bacteriol 113(2):592–598 · doi:10.1128/jb.113.2.592-598.1973
  13. Heaslet H, Shaw B, Mistry A, Miller A (2009) Characterization of the active site of S. aureus monofunctional transglycosylase (Mtg) by site-directed mutation and structural analysis of the protein complexed with moenomycin. J Struct Biol 167(2):129–135 · doi:10.1016/j.jsb.2009.04.010
  14. Jefferies JM, Clarke SC, Webb JS, Kraaijeveld AR (2011) Risk of red queen dynamics in pneumococcal vaccine strategy. Trends Microbiol 19(8):377–381 · doi:10.1016/j.tim.2011.06.001
  15. Kalin M (1998) Pneumococcal serotypes and their clinical relevance. Thorax 53(3):159–162 · doi:10.1136/thx.53.3.159
  16. Kenne L, Lindberg B, Svensson S (1975) The structure of capsular polysaccharide of the pneumococcus type II. Carbohydr Res 40:69–75 · doi:10.1016/s0008-6215(00)82669-5
  17. Komatsuzawa H, Sugai M, Ohta K, Fujiwara T, Nakashima S, Lee CY, Suginaka H (1997) Cloning and characterization of the fmt gene which affects the methicillin-resistance level and autolysis in the presence of triton X-100 in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 41(11):2355–2361 · doi:10.1128/aac.41.11.2355
  18. Komatsuzawa H, Ohta K, Fujiwara T, Choi GH, Labischinski H, Sugai M (2001) Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 203(1):49–54 · doi:10.1111/j.1574-6968.2001.tb10819.x
  19. Kresge N, Simoni RD, Hill RL (2007) t-RNA involvement in peptidoglycan synthesis: the work of Dieter Söll. J Biol Chem 282(26):e20–e21 · doi:10.1016/s0021-9258(20)87397-9
  20. Ludovice AM, Wu SW, De Lencastre H (1998) Molecular cloning and DNA sequencing of the Staphylococcus aureus UDP-N-acetylmuramyl tripeptide synthetase (murE) gene, essential for the optimal expression of methicillin resistance. Microb Drug Resist 4(2):85–90 · doi:10.1089/mdr.1998.4.85
  21. Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O’Malley JM, Cywes-Bentley C, Pier GB (2012) Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetylglucosamine and clumping factor A. PLoS ONE 7(9):e43813 · doi:10.1371/journal.pone.0043813
  22. Marquardt JL, Siegele DA, Kolter R, Walsh CT (1992) Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase. J Bacteriol 174(17):5748–5752 · doi:10.1128/jb.174.17.5748-5752.1992
  23. Mengin-Lecreulx D, Texier L, Rousseau M, van Heijenoort J (1991) The murG gene of Escherichia coli codes for the UDP-N-acetylglucosamine: N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase involved in the membrane steps of peptidoglycan synthesis. J Bacteriol 173(15):4625–4636 · doi:10.1128/jb.173.15.4625-4636.1991
  24. Minnikin DE, Abdolraimzadeh H (1974) Effect of pH on the proportions of polar lipds, in chemostat cultures of Bacillus subtilis. J Bacteriol 120(3):999–10003 · doi:10.1128/jb.120.3.999-1003.1974
  25. Mitchell P, Moyle J (1956) Osmotic structure and function in bacteria. Symp Soc Gen Microbiol 6:150–180
  26. Mitra S, Saeed U, Havlichek DH, Stein GE (2015) Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections. Infect Drug Resist 8:189–197
  27. Norris V, Sweeney S (1993) Deformations in the cytoplasmic membrane of Escherichia coli direct the repair of peptidoglycan. In: de Pedro MA, Höltje JV, Löffelhardt W (eds) Bacterial growth and lysis: metabolism and structure of the bacterial sacculus. Springer, US, pp 375–385 · doi:10.1007/978-1-4757-9359-8_45
  28. Patton GC, van der Donk WA (2005) New developments in lantibiotic biosynthesis and mode of action. Curr Opin Microbiol 8:543–551 · doi:10.1016/j.mib.2005.08.008
  29. Pelton SI, Loughlin AM, Marchant CD (2004) Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J 23(11):1015–1022 · doi:10.1097/01.inf.0000143645.58215.f0
  30. Pless D, Neuhaus FC (1973) Initial membrane reaction in peptidoglycan synthesis. Lipid dependence of phospho-N-acetylmuramylpentapeptide translocase (exchange reaction). J Biol Chem 248(5):1568–1576 · doi:10.1016/s0021-9258(19)44228-2
  31. Pollack JH, Neuhaus FC (1994) Changes in wall teichoic acid during the rod-sphere transition of Bacillus subtilis 168. J Bacteriol 176(23):7252–7259 · doi:10.1128/jb.176.23.7252-7259.1994
  32. Reed P, Atilano ML, Alves R, Hoiczyk E, Sher X, Reichmann NT, Pereira PM, Roemer T, Filipe SR, Periera-Leal JB, Ligoxygakis P, Pinho MG (2015) Staphylococcus aureus survives with a minimal peptidoglycan synthesis machine but sacrifices virulence and antibiotic resistance. PLoS Pathog 11(5):e1004891. doi: 10.1371/journal.ppat.1004891 · doi:10.1371/journal.ppat.1004891
  33. Robbins JB, Schneerson R, Horwith G, Naso R, Fattom A (2004) Staphylococcus aureus type 5 and 8 capsular polysaccharide-protein conjugate vaccines. Am Heart J 147(4):593–598 · doi:10.1016/j.ahj.2004.01.012
  34. Ruiz N (2009) Streptococcus pyogenes YtgP (Spy_0390) complements Escherichia coli strains depleted of the putative peptidoglycan flippase MurJ. Antimicrob Agents Chemother 53(8):3604–3605 · doi:10.1128/aac.00578-09
  35. Schmidt JW, Greenough A, Burns M, Luteran AE, McCafferty DG (2010) Generation of ramoplanin-resistant Staphylococcus aureus. FEMS Microbiol Lett 310(2):104–111 · doi:10.1111/j.1574-6968.2010.02051.x
  36. Venkateswaran PS, Stanton N, Austrian R (1983) Type variation of strains of Streptococcus pneumoniae in capsular serogroup 15. J Infect Dis 147(6):1041–1054 · doi:10.1093/infdis/147.6.1041
  37. Von Aulock S, Hartung T, Hermann C (2007) Comment on “not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compound in Staphylococcus aureus”. J Immunol 178(5):2610–2611 · doi:10.4049/jimmunol.178.5.2610
  38. Ward JB (1973) The chain length of the glycans in bacterial cell walls. J Biochem 133(2):395–398 · doi:10.1042/bj1330395
  39. Xu H, Wang L, Huang J, Zhang Y, Ma F, Wang J, Xu W, Zhang X, Yin Y, Wu K (2015) Pneumococcal wall teichoic acid is required for pathogenesis of Streptococcus pneumoniae in murine models. J Microbiol 53(2):147–154 · doi:10.1007/s12275-015-4616-4

Cited by

See all 292

Metadata

Authors
Rajagopal, M., & Walker, S.
Venue
Current Topics in Microbiology and Immunology
Published
2015
Volume
404
Pages
1-44
ISSN
  • 0070-217X (ISSN-L)
  • 2196-9965
OpenAlex
W2275084756
Cited by
292
References
324
FWCI
13.57
Type
book chapter
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.